By Bill Gerardi, Chief Medical Officer, Medecision
Population health programs have a data problem and a trust problem. They’re the same problem. Health plans and providers don’t lack information. They lack a foundation solid enough to act on that information with confidence, across every team, every workflow, and every partner in the ecosystem.
I’ve made that case in other venues. This month, two independent research firms made it for us.
Named an Innovator, for the Right Reasons
Frost & Sullivan named Medecision an Innovator in its 2026 Frost Radar for US Population Health Management, citing our evolution from a traditional care management vendor into an AI-enabled orchestration and workflow intelligence platform. The firm pointed to our real-time, event-driven approach: the platform ingests raw data directly from warehouses and operational systems rather than depending on prestructured feeds, and triggers interventions based on live signals like ADT events, claims activity, and clinical status changes as they happen, not after the fact. That’s paired with interoperability across 90+ EHRs through FHIR-based APIs aligned to CMS-0057.
Frost & Sullivan’s analysis gets at exactly why this matters. The firm singled us out as a standout case of what’s happening across the broader population health platform market: a hard pivot away from retrospective insight toward platforms built to act. Dashboards tell you what happened. Execution changes what happens next. That shift shows up in the numbers: a 20% improvement in gaps-in-care closure, a 10% reduction in ER utilization, and a 20% gain in administrative efficiency, across the 93 million lives supported on the platform today.
And Rated #1 by the People Who Use Us Every Day
Alongside that recognition, Black Book Market Research ranked Medecision the #1 client-rated vendor in Care Management. Analyst rankings describe where a market is headed. Client rankings describe whether you delivered. Ours came from the people running these platforms inside health plans and provider organizations every day, which is the only scorecard that actually counts.
Together, these two signals point to the same conclusion: momentum built on substance, not a moment.
Why Trust Comes Before Innovation
To improve outcomes for entire patient populations, technology needs to be trusted to build bridges between providers, payers, and others across the ecosystem. Innovation is only as powerful as the foundation it’s built on. The Innovator designation from Frost & Sullivan, along with our other recent industry recognition for care management, signals strategic momentum behind an approach I care deeply about: building trusted, foundational technology that enables meaningful results for the people we ultimately serve.
That order matters. AI in healthcare doesn’t earn adoption because it’s fast or novel. It earns adoption because clinicians and care teams can see how it reached a conclusion, question it, and override it when their judgment says otherwise. Frost & Sullivan pointed to this directly, singling out our multitiered human oversight, risk-based governance methodology, and auditable AI outputs with built-in explainability and citations as a genuine differentiator, not a checkbox. Governance sits at the architecture level, alongside alignment to CMS, NIST, HITRUST, and NAIC frameworks, because a wrong or opaque answer in this industry isn’t just inconvenient. It’s a risk to a person’s care.
That’s the standard we’ve built to, and it’s the standard the market is now grading us against.
Technology Alone Doesn’t Move an Organization. People Do.
Every health plan and provider we work with is managing the same tension: the pressure to modernize and the reality that a platform is only as strong as the teams who trust it enough to use it. Rolling out AI-enabled orchestration isn’t a system swap. It’s a change to how care managers make decisions, how utilization teams work a case, how leadership measures success.
That’s why our approach doesn’t stop at implementation. Frost & Sullivan called this out specifically, pointing to our 2025 acquisition of Excell Healthcare Advisors as evidence that we treat organizational readiness with the same weight as the software itself: helping teams redesign workflows, operationalize governance, and scale adoption long after go-live. Those are the people and process barriers that most often derail digital transformation before the technology ever gets a fair chance. Technology that outpaces the people using it doesn’t get adopted. It gets worked around.
Where This Is Headed
The market is telling us the same thing our clients are: the era of analytics for analytics’ sake is over. Financial accountability, driven by Medicare Advantage, MSSP, and ACO REACH, is forcing organizations to unify clinical, claims, and financial data and act on it in real time. AI that can’t explain itself is losing ground to AI that clinicians can actually trust and use.
I’ll be talking about exactly this at Health Evolution this September: building the trusted foundation that makes innovation possible, and bringing entire organizations along for that shift. These two recognitions aren’t a finish line. They’re confirmation that the foundation we’ve been building is the right one, and momentum to keep building on it.
Want the full story behind the Innovator designation? Read the Frost & Sullivan announcement.